Current State of COVID-19 Point-of-Care Testing: Blood Gases, Biomarkers, and Future Directions

septiembre 23, 2020

This webinar is presented by Dr. Nam Tran.

Watch on-demand

About this webinar

COVID-19 presents new challenges for clinicians working with acute care and point-of-care testing. Radiometer is pleased to sponsor a webinar hosted by the AACC on this urgent and important subject.

Please join Dr. Nam Tran, Professor and Senior Director Clinical Pathology at University of California, Davis (USA) and Health and Director of Clinical Chemistry, Special Chemistry/Toxicology, and Point-of-Care Testing to learn more about:

  • How COVID-19 affects acute care and point-of-care testing (PoCT) workflow and settings
  • What is the published evidence regarding which PoC parameters may predict outcome or prognosis for covid-19 patients?
  • What are the best-practice recommendations for the diagnosis and management of covid-19 patients from a clinical chemistry perspective?

Who should attend?

  • Point of care coordinators
  • ED clinicians
  • ICU clinicians
  • Clinical chemists
  • Lab managers and directors
  • Nurses
  • Respiratory therapists
  • Laboratorians
  • Pathologists

This webinar will:

  • Review how COVID-19 affects acute care and point-of-care testing (PoCT) workflow and settings
  • Present the published evidence regarding which PoC parameters may predict outcome or prognosis for covid-19 patients
  • Discuss the best-practice recommendations for the diagnosis and management of covid-19 patients from a clinical chemistry perspective

About the speaker

Dr. Tran is Professor and Senior Director Clinical Pathology at UC Davis Health (USA). He is also the Director of Clinical Chemistry, Special Chemistry/Toxicology, and Point-of-Care Testing. He completed his PhD degree in Comparative Pathology in 2008 and conducted a postdoctoral training fellowship under the National Institute of Bioimaging and Bioengineering (NIBIB) sponsored UC Davis Point-of-Care Technologies Center focused on developing novel molecular technologies for bedside infectious disease testing. These studies translated to a large multicenter trial evaluating the clinical impact of rapid molecular testing in sepsis in severely burned patients and now real world applications for COVID-19. As the Clinical Pathology Director overseeing the COVID-19 testing response, he and his team were responsible for deploying no less than five SARS-CoV-2 molecular and serology assays over a 60-day period. In addition to his role at UC Davis, he also serves on the California State Governors COVID-19 Testing Task Force.

Details

Topic: Current State of COVID-19 Point-of-Care Testing: Blood Gases, Biomarkers, and Future Directions

Speaker: Nam K. Tran, PhD, HCLD(ABB), FACB | University of California-Davis

Moderator: Larissa S. May, MD, MSPH, MSHS | University of California-Davis

Date: September 23, 2020 | 11:00-12:00pm US ET / 17:00 CET (replay available on demand for a limited time only)

Host: AACC

Sponsor: Radiometer Medical

Unable to attend on the day?

The webinar will be available on-demand. Sign up and be notified of how to watch the webinar afterwards.

En este sitio web se utilizan cookies

Uso de cookies